MetaCap

Aktis Oncology Statistics

NASDAQ: AKTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

16.15-0.25 (-1.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Aktis Oncology by the numbers

Aktis Oncology has a market capitalization of $901.1 million based on 53.93M shares outstanding. With trailing EPS of $-1.80, Aktis Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.7% below its 50-day average and 21.9% below its 200-day average.

Average daily trading volume is 408.46K shares, or about $6.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

AKTS valuation vs. peer median

AKTS compared with the median of 8 peer companies
MetricAKTSPeer medianDifference
Market cap$901.14M$940.99M-4%
Avg. volume408.46K576.70K-29%

Peer median across 8 companies: SVRA, MLTX, CYRX, SPTX, LTGO, MTRI, OMER, PHAR.

Valuation

Price and trading

Previous close
16.40
Open
16.34
Day range
16.00 – 16.74
52-week range
13.96 – 34.19
Beta
—
Volume
374.79K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
901.14M
Forward Pe
-7.15
Eps
-1.80
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
34.19
Week52 Low
13.96
Avg Volume
408.46K
Shares Outstanding
53.93M
Ma50
17.70
Ma200
20.67
Earnings Date
Nov 12, 2026
Pct From52w High
-52.76%
Pct From52w Low
15.69%

Related